参考文献

［1］陆彬.药物新剂型和新技术.北京：人民卫生出版社，1998.

［2］Couteau C，peraz C N，Connan A E，et al.Stripping method to quantify absorption of two sunscreens in human.Int J Pharm，2001，222:153-157.

［3］Howes D，Guy R，Hadrgft J，et al.Methods for Assessing Percutaneous Absorption.ATLA:81-106.

［4］Mose K，Driwet K，Naik A，et al.Passive skin penetration enhancement and its quantification in vitro.Euro J Pharm Biopharm，2001，52:103-112.

［5］冯华，郑家润.经皮吸收实验技术.国外医学皮肤性病学分册，2003，29：243-246.

［6］Touitou E，Medin V M，Horwitz E.Methods for quantitative determination of drug localized in skin.J Control Release，1998，56:7-21.

［7］Seki T，Hosoya O，Yanmazaki T，et al.A rabbit ear flap perfusion expexperiment to evaluate the percutaneous absorption of drugs.Int J pharm，2004，276:29-40.

［8］Cross S，Wu Z，Roberts，M S.Effect of perfusion fiow rate on the tissue uptake of solutes after dermal application using the rate isolated perfused hinglimb preparation.J Pharm Pharmacol，1994，46:844-850.

［9］Cantor A S.Drug and excipient diffusion and solubility in acrylate adhesives measured by infrared-attenuated total reflectance（IR-ATR）spectroscopy.J Controlled Release，1999，61:219-231.

［10］姜丽丽，徐敏，金大源等.α-细辛醚贴剂的家兔相对生物利用度研究.中国药学杂志，2002，19：390-391.

［11］张学军，刘维达，何春涤.现代皮肤病学基础.北京：人民卫生出版社，2001.

［12］Benfeldt E，Groth L.Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration.Acta Derm Venereol，1998，78:274-278.

［13］Williams A C.Structure and Fuction of Human Skin.In:Williams A C.Transdermal and Topical Drug Delivery. JA Majors Co，2003:1-25.

［14］Anigbogu A N C，Williams A C，Barry B W.Permeation characteristics of 8-methoxypsoralen through human skin:relevance to clinical treatment.J P harm Pharmacol，1996，48:357-366.

［15］郑俊民.经皮给药新剂型.北京：人民卫生出版社，1997：36-39.

［16］Cross S E，Roberts M S.Subcutaneous absorption kinetics of interferon and other solutes.J Pharm Pharmacol， 1993，45:606-609.

［17］King M J，Michel D，Foldvari M.Evidence for lymphatic transport of insulin by topically applied biphasic vesicles.J Pharm Parmacol，2003，55:1339-1344.

［18］Flynn G L.Cutaneous and Transdermal Delivery-Processes and Systems of Delivery.In:Banker G S，Rhodes C T， eds.Modern Pharmaceutics.New York:Marcel Dekker，2002:187-223.

［19］Lampe M A，Burligame A L，Whitney J，et al.Human stratum corneum lipids:characterisation and regional variations.J Lipid Res，1983，24:120-130.

［20］Finnin B C，Morgan T M.Transdermal penetration enhancers:application，limitations，and potential.J Pharm Sci， 1999，88:955-958.

［21］Modamio P，Lastra C F，Marino E L.A comparative in vitro study of percutaneous penetration of β-blockers in human skin.Int J Pharm，2000，194:249-259.

［22］Rathbone M J，Hadgraft J，Roberts M S.Modified-Release Drug Delivery Technology.New York:Marcel Dekker， 2003:488.

［23］Qi X H，Ackermann C，Sun D，et al.Physicochemical characterization and percutaneous delivery of 2，3，5，6-tetra-methylpyrazine.Int J Pharm，2003，253:177-183.

［24］刘建平，李运曼，张灵霞等.止咳平喘膜剂的研制与穴位作用机理初步探讨.中国药科大学学报，2000，31：426-428.

［25］Berardesca E，Maibach H I.Racial differences in pharmacodynamic response to nicotinates in vivo in human skin:black and white.Acta Derm Venereol，1990，70:63-66.

［26］Wilhelm K，Surber C，Maibach H I.Effect of sodium laurylsulfate-induced skin irritation on in vivo percutaneous absorption of four drugs.J Invest Dermatol，1991，97:927-932.

［27］Wertz P W，Miethke M C，Long S A，et al.The composition of the ceramides from human stratum corneum and from comedones.J Invest Dermatol，1985，84:410-412.

［28］Roberts M S，Walters K A.The relationship between structure and barrier function of skin.In:Roberts M S， Walters K A，eds.Dermal Absorption and Toxicity Assessment.New York:Marcel Dwkker，1998:chapter 1.

［29］Fenske N A，Lober C W.Structural and functional changes of normal aging skin.J Am Acad Dermatol，1986，48:571-585.

［30］Berardesca E，Rigal J L，et al.In vivo biophysical characterization of skin physiological differences in races.Dermatologica， 1991，182:89-93.

［31］Lotte C，Wester R C，Rougier A，et al.Racial differences in the vivo percutaneous absorption of some organic compounds:a comparison between black，Caucasian and Asian subjects.Arch Dermatol Res，1993，284:456-459.

［32］Goldin B，Touitou E.Ethosomes:New Prospects in Transdermal Delivery.Crit Rev Ther Drug，2003，20:63-102.

［33］Adrian C W，Barry W B.Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement.Pharm Res，1991，8:17-24.

［34］Abraham M H，Chadha H S，Martins F，et al.Hydrogen bonding part 46:A review of the correlation and prediction of transport properties by an LFER method:physicochemical properties，brain penetration and skin permeability.Pestic Sci，1999，55:78-88.

［35］Patel H，Berge W，Cronin M TD.Quantitative structure-activity relationship（QSARs）for the prediction and skin permeation of exogenous chemicals.Chemosphere，2002，48:603-613.

［36］Magnusson B M，Anissimov Y G，Cross S E，et al.Molecular size as the main determinant of solute maximum flux across skin.J Invest Dermatol，2004，122:993-999.

［37］李娟，纪涛，王雪松.美洛昔康凝胶剂的制备及其经皮吸收研究.中国新药杂志，2002，11：937-939.

［38］刘未艾，叶德宝.穴位贴敷疗法透皮给药的研究进展.中医药通报，2004，3：59-62.

［39］魏莉，蔡贞贞，徐莲英.当归及其复方透皮吸收特性的研究.2000，25：32-34.